SCHEMBL1074801

SCHEMBL1074801

COc1cc(F)c(-c2c(C)nc(Cl)n2-c2cccc(Cl)c2)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.40
PDE11A Q9HCR9 1/20 0.39
MALT1 Q9UDY8 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MPO P05164 1/20 0.38
TSHR P16473 2/20 0.37
ALDH1A1 P00352 2/20 0.37
USP2 O75604 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
NPBWR1 P48145 1/20 0.37
MCHR1 Q99705 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1225303 0.91 CYP1A2 (0.37) CYP1A2MALT1SMN1; SMN2ALDH1A1HPGD
SCHEMBL1076149 0.88 CYP1A2 (0.36) CYP1A2MALT1SMN1; SMN2TSHRALDH1A1
SCHEMBL1074420 0.87 CYP1A2 (0.38) CYP1A2HSD17B10
SCHEMBL1075011 0.86 GLA (0.40) CYP1A2SMN1; SMN2TSHRCYP3A4CYP2C9
SCHEMBL1074585 0.84 PDE4B (0.37) CYP1A2
SCHEMBL1076597 0.84 ALDH1A1 (0.36) CYP1A2SMN1; SMN2ALDH1A1HTTHPGD
SCHEMBL1073566 0.83 SMN1; SMN2 (0.44) CYP1A2PDE11AMALT1SMN1; SMN2MPO
SCHEMBL1224510 0.83 KCNJ5 (0.38) CYP1A2
SCHEMBL1075676 0.82 CYP11B1 (0.40) CYP1A2
SCHEMBL1073034 0.81 CYP1A2 (0.34) CYP1A2TSHRALDH1A1USP2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-24 US claimed
EP-2274284-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. Du Pont de Nemours and Company (US) 2011-01-19 EP claimed
WO-2009137651-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-11-12 WO claimed
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-24 US disclosed
EP-2274284-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. Du Pont de Nemours and Company (US) 2011-01-19 EP disclosed
WO-2009137651-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES CBR3, NOX3, CBR1 CYP1A2 9/4885PDE11A 3489/4885MALT1 572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.